Veto cells may help stem cell transplants work better and safer
NCT ID NCT03622788
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 24 times
Summary
This early-phase trial tests whether adding special 'veto' cells to a stem cell transplant can help donor cells grow in the patient's body without causing severe graft-versus-host disease. It includes 16 people aged 12-75 with various blood cancers or bone marrow failure. The veto cells are treated with cytokines to protect the donor cells and reduce complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.